216 related articles for article (PubMed ID: 29782587)
1. Skeletal standardized uptake values obtained by quantitative SPECT/CT as an osteoblastic biomarker for the discrimination of active bone metastasis in prostate cancer.
Kuji I; Yamane T; Seto A; Yasumizu Y; Shirotake S; Oyama M
Eur J Hybrid Imaging; 2017; 1(1):2. PubMed ID: 29782587
[TBL] [Abstract][Full Text] [Related]
2. Comparison of standardized uptake values between
Arvola S; Jambor I; Kuisma A; Kemppainen J; Kajander S; Seppänen M; Noponen T
EJNMMI Res; 2019 Jan; 9(1):6. PubMed ID: 30680469
[TBL] [Abstract][Full Text] [Related]
3. Skeletal standardized uptake values obtained using quantitative SPECT/CT for the detection of bone metastases in patients with lung adenocarcinoma.
Lin L; Zheng R; Geng J; Wang X; Li M; Fan R; Zheng Y; Yang K
Front Med (Lausanne); 2023; 10():1119214. PubMed ID: 36817798
[TBL] [Abstract][Full Text] [Related]
4. Quantitative bone SPECT/CT: high specificity for identification of prostate cancer bone metastases.
Tabotta F; Jreige M; Schaefer N; Becce F; Prior JO; Nicod Lalonde M
BMC Musculoskelet Disord; 2019 Dec; 20(1):619. PubMed ID: 31878904
[TBL] [Abstract][Full Text] [Related]
5. Quantitative [
Tanaka K; Norikane T; Mitamura K; Yamamoto Y; Maeda Y; Fujimoto K; Takami Y; Ishimura M; Arai-Okuda H; Tohi Y; Kudomi N; Sugimoto M; Nishiyama Y
EJNMMI Phys; 2022 Dec; 9(1):83. PubMed ID: 36469149
[TBL] [Abstract][Full Text] [Related]
6. Maximum standardized uptake value from quantitative bone single-photon emission computed tomography/computed tomography in differentiating metastatic and degenerative joint disease of the spine in prostate cancer patients.
Mohd Rohani MF; Mat Nawi N; Shamim SE; Wan Sohaimi WF; Wan Zainon WMN; Musarudin M; Said MA; Hashim H
Ann Nucl Med; 2020 Jan; 34(1):39-48. PubMed ID: 31612417
[TBL] [Abstract][Full Text] [Related]
7. The value of skeletal standardized uptake values obtained by quantitative single-photon emission computed tomography-computed tomography in differential diagnosis of bone metastases.
Zhang Y; Li B; Yu H; Song J; Zhou Y; Shi H
Nucl Med Commun; 2021 Jan; 42(1):63-67. PubMed ID: 33044406
[TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of
Oya T; Ichikawa Y; Nakamura S; Tomita Y; Sasaki T; Inoue T; Sakuma H
Ann Nucl Med; 2023 Jun; 37(6):360-370. PubMed ID: 36947324
[TBL] [Abstract][Full Text] [Related]
10. Standardized uptake values of
Qi N; Meng Q; You Z; Chen H; Shou Y; Zhao J
BMC Med Imaging; 2021 Feb; 21(1):39. PubMed ID: 33639883
[TBL] [Abstract][Full Text] [Related]
11. A retrospective study of SPECT/CT scans using SUV measurement of the normal pelvis with Tc-99m methylene diphosphonate.
Wang R; Duan X; Shen C; Han D; Ma J; Wu H; Xu X; Qin T; Fan Q; Zhang Z; Shi W; Guo Y
J Xray Sci Technol; 2018; 26(6):895-908. PubMed ID: 30103368
[TBL] [Abstract][Full Text] [Related]
12. SUV measurement of normal vertebrae using SPECT/CT with Tc-99m methylene diphosphonate.
Kaneta T; Ogawa M; Daisaki H; Nawata S; Yoshida K; Inoue T
Am J Nucl Med Mol Imaging; 2016; 6(5):262-268. PubMed ID: 27766184
[TBL] [Abstract][Full Text] [Related]
13. Quantification evaluation of
Huang K; Feng Y; Liu D; Liang W; Li L
Ann Nucl Med; 2020 Feb; 34(2):136-143. PubMed ID: 31768820
[TBL] [Abstract][Full Text] [Related]
14. Normal Skeletal Standardized Uptake Values Obtained from Quantitative Single-Photon Emission Computed Tomography/Computed Tomography: Time-Dependent Study on Breast Cancer Patients.
Nautiyal A; Jha AK; Mithun S; Sawant V; Jadhav R; Khairnar K; Rangarajan V
Indian J Nucl Med; 2021; 36(4):398-411. PubMed ID: 35125758
[TBL] [Abstract][Full Text] [Related]
15. Comparison of bone single-photon emission computed tomography (SPECT)/CT and bone scintigraphy in assessing knee joints.
An YS; Park DY; Min BH; Lee SJ; Yoon JK
BMC Med Imaging; 2021 Mar; 21(1):60. PubMed ID: 33771130
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of
Hu X; Cao Y; Ji B; Zhao M; Wen Q; Chen B
Front Med (Lausanne); 2023; 10():1201977. PubMed ID: 37588003
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of quantitative bone SPECT/CT for bone metastasis diagnosis.
Ikeda T; Kitajima K; Tsuchitani T; Takahashi Y; Hama Y; Kotura N
Hell J Nucl Med; 2022; 25(3):253-259. PubMed ID: 36507881
[TBL] [Abstract][Full Text] [Related]
18. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
Qiu ZL; Xue YL; Song HJ; Luo QY
Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
[TBL] [Abstract][Full Text] [Related]
20. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
